Skip to main content
SpringerLink
Log in

Drug-induced interstitial lung disease

  • Clinical study
  • Published:
Reactions Weekly Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Reference

  • Drug-induced interstitial lung disease: a real-world pharmacovigilance study of the FDA Adverse Event Reporting System from 2004 to 2021 Therapeutic Advances in Drug Safety : 27 Jan 2024. Available from: URL: https://doi.org/10.1177/20420986231224227

Download references

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Drug-induced interstitial lung disease. Reactions Weekly 1995, 10 (2024). https://doi.org/10.1007/s40278-024-53273-6

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40278-024-53273-6

Search

Navigation